ALOX12 and Alzheimer disease: In the previous sections, we found that WFDC12 may regulate AD immune inflammation by affecting the metabolism of lipoxygenase ALOX12/15 in the AA metabolic pathway and promoting the production and accumulation of inflammatory mediators 12/15-HETE.